| RRC ID |
87008
|
| Author |
Flores-Santibañez F, Rennen S, Fernández D, De Nolf C, Van De Velde E, Gaete González S, Fuentes C, Moreno C, Figueroa D, Lladser Á, Iwawaki T, Bono MR, Janssens S, Osorio F.
|
| Title |
Nuanced role for dendritic cell intrinsic IRE1 RNase in the regulation of antitumor adaptive immunity.
|
| Journal |
Front Immunol
|
| Abstract |
In cancer, activation of the IRE1/XBP1s axis of the unfolded protein response (UPR) promotes immunosuppression and tumor growth, by acting in cancer cells and tumor infiltrating immune cells. However, the role of IRE1/XBP1s in dendritic cells (DCs) in tumors, particularly in conventional type 1 DCs (cDC1s) which are cellular targets in immunotherapy, has not been fully elucidated. Here, we studied the role of IRE1/XBP1s in subcutaneous B16/B78 melanoma and MC38 tumors by generating loss-of-function models of IRE1 and/or XBP1s in DCs or in cDC1s. Data show that concomitant deletion of the RNase domain of IRE1 and XBP1s in DCs and cDC1s does not influence the kinetics of B16/B78 and MC38 tumor growth or the effector profile of tumor infiltrating T cells. A modest effect is observed in mice bearing single deletion of XBP1s in DCs, which showed slight acceleration of melanoma tumor growth and dysfunctional T cell responses, however, this effect was not recapitulated in animals lacking XBP1 only in cDC1s. Thus, evidence presented here argues against a general pro-tumorigenic role of the IRE1/XBP1s pathway in tumor associated DC subsets.
|
| Volume |
14
|
| Pages |
1209588
|
| Published |
2023-1-1
|
| DOI |
10.3389/fimmu.2023.1209588
|
| PMID |
37346037
|
| PMC |
PMC10279875
|
| MeSH |
Adaptive Immunity
Animals
Dendritic Cells
Endoribonucleases / genetics
Endoribonucleases / metabolism
Melanoma, Experimental* / metabolism
Mice
Protein Serine-Threonine Kinases / genetics
Protein Serine-Threonine Kinases / metabolism
Ribonuclease, Pancreatic / metabolism
Ribonucleases* / metabolism
|
| Resource |
| Mice |
RBRC01099 |
